This report contains market size and forecasts of Vascular Endothelial Growth Factor (VEGF) Antibodies in global, including the following market information:
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Vascular Endothelial Growth Factor (VEGF) Antibodies companies in 2021 (%)
The global Vascular Endothelial Growth Factor (VEGF) Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bevacizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vascular Endothelial Growth Factor (VEGF) Antibodies include Roche, Novartis, Sanofi, Regeneron, Bayer, AstraZeneca, Pfizer, Merck and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vascular Endothelial Growth Factor (VEGF) Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, by Type, 2021 (%)
Bevacizumab
Ranibizumab
Aflibercept
Others
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
Others
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies revenues share in global market, 2021 (%)
Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Vascular Endothelial Growth Factor (VEGF) Antibodies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Sanofi
Regeneron
Bayer
AstraZeneca
Pfizer
Merck
Eli Lilly
GlaxoSmithKline
Bristol-Myer Squibb
Boehringer Ingelheim
Abcam Plc